BioROSA Technologies
About:
BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders.
Website: https://therosa.bio/
Twitter/X: biorosatech
Top Investors: IndieBio, SOSV, Bioverge, Zoic Capital, Autism Impact Fund
Description:
BioROSA Technologies creates a biologically-based diagnostic standard of care for Autism Spectrum Disorders. The company was founded in 2018 and is based in Belmont, Massachusetts.
Total Funding Amount:
$745000
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Belmont, Massachusetts, United States
Founded Date:
2018-01-01
Contact Email:
Arlen(AT)therosa.bio
Founders:
John Slattery, Marie Causey
Number of Employees:
1-10
Last Funding Date:
2022-11-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai